UniProtKB - P48730 (KC1D_HUMAN)
(max 400 entries)x
Your basket is currently empty.
Select item(s) and click on "Add to basket" to create your own collection here
(400 entries max)
Protein
Casein kinase I isoform delta
Gene
CSNK1D
Organism
Homo sapiens (Human)
Status
Functioni
Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. In balance with PP1, determines the circadian period length through the regulation of the speed and rhythmicity of PER1 and PER2 phosphorylation. Controls PER1 and PER2 nuclear transport and degradation. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate.17 Publications
Miscellaneous
May be involved in Alzheimer disease by phosphorylating MAPT/TAU.1 Publication
Catalytic activityi
ATP + a protein = ADP + a phosphoprotein.
ATP + [tau protein] = ADP + [tau protein] phosphate.
Enzyme regulationi
Exhibits substrate-dependent heparin activation. Drug-mediated inhibition leads to a delay of the oscillations with the magnitude of this effect dependent upon the timing of drug administration. Inhibited by phosphorylation. Repressed by 3-[(2,4,6-trimethoxyphenyl)methylidenyl]-indolin-2-one (IC261), N-(2-aminoethyl)-5-chloroisoquinoline-8-sulfonamide (CKI-7), 4-[4-(2,3-dihydro-benzo[1,4]dioxin-6-yl)-5-pyridin-2-yl-1H-imidazol-2-yl]benzamide (D4476), 3,4-diaryl-isoxazoles and -imidazoles, and 4-(3-cyclohexyl-5-(4-fluoro-phenyl)-3H-imidazol-4-yl) pyrimidin-2-ylamine (PF670462, PF670).10 Publications
Kineticsi
Maximal velocity nearly identical for the reactions with alpha-casein and PER2 peptide.
- KM=36.5 µM for alpha-casein1 Publication
- KM=635.8 µM for PER2 peptide1 Publication
- KM=180.6 µM for ATP1 Publication
Sites
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Binding sitei | 38 | ATPPROSITE-ProRule annotation | 1 | |
| Active sitei | 128 | Proton acceptorPROSITE-ProRule annotation | 1 |
Regions
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Nucleotide bindingi | 15 – 23 | ATPPROSITE-ProRule annotation | 9 |
GO - Molecular functioni
- ATP binding Source: UniProtKB-KW
- cadherin binding Source: BHF-UCL
- glycoprotein binding Source: Ensembl
- peptide binding Source: Ensembl
- protein kinase activity Source: UniProtKB
- protein serine/threonine kinase activity Source: ParkinsonsUK-UCL
- tau-protein kinase activity Source: UniProtKB-EC
GO - Biological processi
- cellular response to nerve growth factor stimulus Source: Ensembl
- ciliary basal body docking Source: Reactome
- circadian regulation of gene expression Source: UniProtKB
- COPII vesicle coating Source: Reactome
- endocytosis Source: GO_Central
- G2/M transition of mitotic cell cycle Source: Reactome
- Golgi organization Source: SYSCILIA_CCNET
- microtubule nucleation Source: SYSCILIA_CCNET
- non-motile cilium assembly Source: SYSCILIA_CCNET
- peptidyl-serine phosphorylation Source: ParkinsonsUK-UCL
- positive regulation of canonical Wnt signaling pathway Source: BHF-UCL
- positive regulation of non-canonical Wnt signaling pathway Source: ParkinsonsUK-UCL
- positive regulation of proteasomal ubiquitin-dependent protein catabolic process Source: UniProtKB
- positive regulation of protein phosphorylation Source: BHF-UCL
- positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation Source: ParkinsonsUK-UCL
- protein localization to centrosome Source: SYSCILIA_CCNET
- protein localization to cilium Source: SYSCILIA_CCNET
- protein localization to Golgi apparatus Source: SYSCILIA_CCNET
- protein phosphorylation Source: UniProtKB
- regulation of cell shape Source: GO_Central
- regulation of circadian rhythm Source: UniProtKB
- rRNA processing Source: Reactome
- spindle assembly Source: UniProtKB
- Wnt signaling pathway Source: UniProtKB-KW
Keywordsi
| Molecular function | Kinase, Serine/threonine-protein kinase, Transferase |
| Biological process | Biological rhythms, Wnt signaling pathway |
| Ligand | ATP-binding, Nucleotide-binding |
Enzyme and pathway databases
| BRENDAi | 2.7.11.1. 2681. |
| Reactomei | R-HSA-204005. COPII (Coat Protein 2) Mediated Vesicle Transport. R-HSA-2565942. Regulation of PLK1 Activity at G2/M Transition. R-HSA-380259. Loss of Nlp from mitotic centrosomes. R-HSA-380270. Recruitment of mitotic centrosome proteins and complexes. R-HSA-380284. Loss of proteins required for interphase microtubule organization from the centrosome. R-HSA-400253. Circadian Clock. R-HSA-5620912. Anchoring of the basal body to the plasma membrane. R-HSA-6791226. Major pathway of rRNA processing in the nucleolus and cytosol. R-HSA-8854518. AURKA Activation by TPX2. |
| SABIO-RKi | P48730. |
| SignaLinki | P48730. |
| SIGNORi | P48730. |
Names & Taxonomyi
| Protein namesi | |
| Gene namesi | Name:CSNK1D Synonyms:HCKID |
| Organismi | Homo sapiens (Human) |
| Taxonomic identifieri | 9606 [NCBI] |
| Taxonomic lineagei | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
| Proteomesi |
|
Organism-specific databases
| HGNCi | HGNC:2452. CSNK1D. |
Subcellular locationi
- Cytoplasm
- Nucleus
- Cytoplasm › cytoskeleton › microtubule organizing center › centrosome
- Cytoplasm › perinuclear region
- Cell membrane
- Cytoplasm › cytoskeleton › spindle
- Golgi apparatus
Note: Localized at mitotic spindle microtubules, and at the centrosomes and interphase in interphase cells. Recruited to the spindle apparatus and the centrosomes in response to DNA-damage. Correct subcellular localization requires kinase activity.
GO - Cellular componenti
- centrosome Source: UniProtKB
- cytosol Source: Reactome
- endoplasmic reticulum-Golgi intermediate compartment membrane Source: Reactome
- Golgi apparatus Source: UniProtKB
- Golgi membrane Source: GOC
- neuron projection Source: Ensembl
- nucleoplasm Source: Reactome
- nucleus Source: UniProtKB
- perinuclear region of cytoplasm Source: UniProtKB
- plasma membrane Source: UniProtKB
- spindle Source: UniProtKB
- spindle microtubule Source: UniProtKB
Keywords - Cellular componenti
Cell membrane, Cytoplasm, Cytoskeleton, Golgi apparatus, Membrane, NucleusPathology & Biotechi
Involvement in diseasei
Advanced sleep phase syndrome, familial, 2 (FASPS2)2 Publications
The disease is caused by mutations affecting the gene represented in this entry.
Disease descriptionA disorder characterized by very early sleep onset and offset. Individuals are 'morning larks' with a 4 hours advance of the sleep, temperature and melatonin rhythms.
See also OMIM:615224| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Natural variantiVAR_029075 | 44 | T → A in FASPS2; strongly reduces kinase activity. 2 PublicationsCorresponds to variant dbSNP:rs104894561Ensembl. | 1 | |
| Natural variantiVAR_069801 | 46 | H → R in FASPS2; strongly reduces kinase activity. 1 PublicationCorresponds to variant dbSNP:rs397514693Ensembl. | 1 |
Mutagenesis
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Mutagenesisi | 38 | K → M: Impaired kinase activity and abnormal subcellular localization with exclusive accumulation to the nucleus. 1 Publication | 1 | |
| Mutagenesisi | 176 | T → I: Impaired kinase activity and abnormal subcellular localization with exclusive accumulation to the nucleus. 1 Publication | 1 |
Keywords - Diseasei
Disease mutationOrganism-specific databases
| DisGeNETi | 1453. |
| MalaCardsi | CSNK1D. |
| MIMi | 615224. phenotype. |
| OpenTargetsi | ENSG00000141551. |
| Orphaneti | 164736. Familial advanced sleep-phase syndrome. |
| PharmGKBi | PA26952. |
Chemistry databases
| ChEMBLi | CHEMBL2828. |
| GuidetoPHARMACOLOGYi | 1997. |
Polymorphism and mutation databases
| BioMutai | CSNK1D. |
| DMDMi | 27923980. |
PTM / Processingi
Molecule processing
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| ChainiPRO_0000192833 | 1 – 415 | Casein kinase I isoform deltaAdd BLAST | 415 |
Amino acid modifications
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Modified residuei | 328 | PhosphoserineCombined sources | 1 | |
| Modified residuei | 331 | PhosphoserineCombined sources | 1 | |
| Modified residuei | 370 | PhosphoserineBy similarity | 1 | |
| Modified residuei | 375 | Omega-N-methylarginineBy similarity | 1 | |
| Modified residuei | 382 | PhosphoserineCombined sources | 1 | |
| Modified residuei | 383 | PhosphoserineCombined sources | 1 | |
| Modified residuei | 384 | PhosphoserineCombined sources | 1 | |
| Modified residuei | 407 | PhosphoserineCombined sources | 1 | |
| Modified residuei | 411 | PhosphoserineCombined sources | 1 |
Post-translational modificationi
Autophosphorylated on serine and threonine residues; this autophosphorylation represses activity. Reactivated by phosphatase-mediated dephosphorylation. May be dephosphorylated by PP1.
Keywords - PTMi
Methylation, PhosphoproteinProteomic databases
| EPDi | P48730. |
| MaxQBi | P48730. |
| PaxDbi | P48730. |
| PeptideAtlasi | P48730. |
| PRIDEi | P48730. |
| TopDownProteomicsi | P48730-1. [P48730-1] |
PTM databases
| iPTMneti | P48730. |
| PhosphoSitePlusi | P48730. |
Expressioni
Tissue specificityi
Expressed in all tissues examined, including brain, heart, lung, liver, pancreas, kidney, placenta and skeletal muscle. However, kinase activity is not uniform, with highest kinase activity in splenocytes. In blood, highly expressed in hemopoietic cells and mature granulocytes. Also found in monocytes and lymphocytes.2 Publications
Developmental stagei
Highly present in extravillous trophoblast cells, which are present at the placenta implantation site and invade the decidua and decidual vessels.1 Publication
Gene expression databases
| Bgeei | ENSG00000141551. |
| CleanExi | HS_CSNK1D. |
| ExpressionAtlasi | P48730. baseline and differential. |
| Genevisiblei | P48730. HS. |
Organism-specific databases
| HPAi | CAB015410. |
Interactioni
Subunit structurei
Binds to DNMT1 and MAP1A (By similarity). Monomer. Component of the circadian core oscillator, which includes the CRY proteins, CLOCK, or NPAS2, ARTNL/BMAL1 or ARTNL2/BMAL2, CSNK1D and/or CSNK1E, TIMELESS and the PER proteins. Interacts directly with PER1 and PER2 which may lead to their degradation. Interacts with MAPT/TAU, SNAPIN, DBNDD2, AIB1/NCOA3 and ESR1. AKAP9/AKAP450 binding promotes centrosomal subcellular location. Binds to tubulins in mitotic cells upon DNA damage.By similarity9 Publications
Binary interactionsi
GO - Molecular functioni
- cadherin binding Source: BHF-UCL
- glycoprotein binding Source: Ensembl
Protein-protein interaction databases
| BioGridi | 107837. 87 interactors. |
| DIPi | DIP-39735N. |
| IntActi | P48730. 43 interactors. |
| MINTi | MINT-1454355. |
| STRINGi | 9606.ENSP00000324464. |
Chemistry databases
| BindingDBi | P48730. |
Structurei
Secondary structure
Legend: HelixTurnBeta strandPDB Structure known for this area
Show more details| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Beta strandi | 3 – 5 | Combined sources | 3 | |
| Turni | 6 – 8 | Combined sources | 3 | |
| Beta strandi | 9 – 16 | Combined sources | 8 | |
| Beta strandi | 21 – 28 | Combined sources | 8 | |
| Turni | 29 – 32 | Combined sources | 4 | |
| Beta strandi | 33 – 41 | Combined sources | 9 | |
| Beta strandi | 44 – 46 | Combined sources | 3 | |
| Helixi | 49 – 59 | Combined sources | 11 | |
| Beta strandi | 68 – 74 | Combined sources | 7 | |
| Beta strandi | 77 – 83 | Combined sources | 7 | |
| Helixi | 89 – 95 | Combined sources | 7 | |
| Turni | 96 – 98 | Combined sources | 3 | |
| Helixi | 102 – 121 | Combined sources | 20 | |
| Helixi | 131 – 133 | Combined sources | 3 | |
| Beta strandi | 134 – 136 | Combined sources | 3 | |
| Helixi | 139 – 141 | Combined sources | 3 | |
| Beta strandi | 145 – 147 | Combined sources | 3 | |
| Beta strandi | 154 – 157 | Combined sources | 4 | |
| Turni | 159 – 161 | Combined sources | 3 | |
| Helixi | 177 – 179 | Combined sources | 3 | |
| Helixi | 182 – 185 | Combined sources | 4 | |
| Helixi | 192 – 208 | Combined sources | 17 | |
| Turni | 212 – 215 | Combined sources | 4 | |
| Helixi | 223 – 234 | Combined sources | 12 | |
| Helixi | 237 – 240 | Combined sources | 4 | |
| Turni | 241 – 243 | Combined sources | 3 | |
| Helixi | 247 – 257 | Combined sources | 11 | |
| Helixi | 266 – 279 | Combined sources | 14 | |
| Turni | 289 – 292 | Combined sources | 4 |
3D structure databases
| Select the link destinations: PDBei RCSB PDBi PDBji Links Updated | PDB entry | Method | Resolution (Å) | Chain | Positions | PDBsum |
| 3UYS | X-ray | 2.30 | A/B/C/D | 1-294 | [»] | |
| 3UYT | X-ray | 2.00 | A/B/C/D | 1-294 | [»] | |
| 3UZP | X-ray | 1.94 | A/B | 1-294 | [»] | |
| 4HGT | X-ray | 1.80 | A/B | 1-294 | [»] | |
| 4HNF | X-ray | 2.07 | A/B | 1-294 | [»] | |
| 4KB8 | X-ray | 1.95 | A/B/C/D | 3-317 | [»] | |
| 4KBA | X-ray | 1.98 | A/B/C/D | 3-317 | [»] | |
| 4KBC | X-ray | 1.98 | A/B | 1-317 | [»] | |
| 4KBK | X-ray | 2.10 | A/B/C/D | 3-317 | [»] | |
| 4TN6 | X-ray | 2.41 | A/B | 1-301 | [»] | |
| 4TW9 | X-ray | 2.40 | A/B | 1-295 | [»] | |
| 4TWC | X-ray | 1.70 | A/B | 1-295 | [»] | |
| 5IH4 | X-ray | 1.90 | A | 1-294 | [»] | |
| 5IH5 | X-ray | 2.25 | A | 1-294 | [»] | |
| 5IH6 | X-ray | 2.30 | A | 1-294 | [»] | |
| 5MQV | X-ray | 2.15 | A/B/C/D/E/F | 1-294 | [»] | |
| ProteinModelPortali | P48730. | |||||
| SMRi | P48730. | |||||
| ModBasei | Search... | |||||
| MobiDBi | Search... | |||||
Family & Domainsi
Domains and Repeats
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Domaini | 9 – 277 | Protein kinasePROSITE-ProRule annotationAdd BLAST | 269 |
Region
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Regioni | 278 – 364 | Centrosomal localization signal (CLS)Add BLAST | 87 | |
| Regioni | 317 – 342 | AutoinhibitoryBy similarityAdd BLAST | 26 |
Sequence similaritiesi
Belongs to the protein kinase superfamily. CK1 Ser/Thr protein kinase family. Casein kinase I subfamily.Curated
Phylogenomic databases
| eggNOGi | KOG1164. Eukaryota. ENOG410XPGP. LUCA. |
| GeneTreei | ENSGT00760000119040. |
| HOGENOMi | HOG000182055. |
| HOVERGENi | HBG000176. |
| InParanoidi | P48730. |
| KOi | K08959. |
| PhylomeDBi | P48730. |
| TreeFami | TF300544. |
Family and domain databases
| InterProi | View protein in InterPro IPR011009. Kinase-like_dom. IPR000719. Prot_kinase_dom. IPR017441. Protein_kinase_ATP_BS. IPR008271. Ser/Thr_kinase_AS. |
| Pfami | View protein in Pfam PF00069. Pkinase. 1 hit. |
| SMARTi | View protein in SMART SM00220. S_TKc. 1 hit. |
| SUPFAMi | SSF56112. SSF56112. 1 hit. |
| PROSITEi | View protein in PROSITE PS00107. PROTEIN_KINASE_ATP. 1 hit. PS50011. PROTEIN_KINASE_DOM. 1 hit. PS00108. PROTEIN_KINASE_ST. 1 hit. |
Sequences (2)i
Sequence statusi: Complete.
This entry describes 2 isoformsi produced by alternative splicing. AlignAdd to basket
Isoform 1 (identifier: P48730-1) [UniParc]FASTAAdd to basket
This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.
10 20 30 40 50
MELRVGNRYR LGRKIGSGSF GDIYLGTDIA AGEEVAIKLE CVKTKHPQLH
60 70 80 90 100
IESKIYKMMQ GGVGIPTIRW CGAEGDYNVM VMELLGPSLE DLFNFCSRKF
110 120 130 140 150
SLKTVLLLAD QMISRIEYIH SKNFIHRDVK PDNFLMGLGK KGNLVYIIDF
160 170 180 190 200
GLAKKYRDAR THQHIPYREN KNLTGTARYA SINTHLGIEQ SRRDDLESLG
210 220 230 240 250
YVLMYFNLGS LPWQGLKAAT KRQKYERISE KKMSTPIEVL CKGYPSEFAT
260 270 280 290 300
YLNFCRSLRF DDKPDYSYLR QLFRNLFHRQ GFSYDYVFDW NMLKFGASRA
310 320 330 340 350
ADDAERERRD REERLRHSRN PATRGLPSTA SGRLRGTQEV APPTPLTPTS
360 370 380 390 400
HTANTSPRPV SGMERERKVS MRLHRGAPVN ISSSDLTGRQ DTSRMSTSQI
410
PGRVASSGLQ SVVHR
Experimental Info
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Sequence conflicti | 330 | A → D in AAC50807 (PubMed:8786104).Curated | 1 |
Natural variant
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Natural variantiVAR_029075 | 44 | T → A in FASPS2; strongly reduces kinase activity. 2 PublicationsCorresponds to variant dbSNP:rs104894561Ensembl. | 1 | |
| Natural variantiVAR_069801 | 46 | H → R in FASPS2; strongly reduces kinase activity. 1 PublicationCorresponds to variant dbSNP:rs397514693Ensembl. | 1 | |
| Natural variantiVAR_036451 | 97 | S → C in breast cancer samples; infiltrating ductal carcinoma; somatic mutation. 2 Publications | 1 | |
| Natural variantiVAR_042081 | 401 | P → A1 PublicationCorresponds to variant dbSNP:rs56124628Ensembl. | 1 |
Alternative sequence
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Alternative sequenceiVSP_010253 | 400 – 415 | IPGRV…SVVHR → NSIPFEHHGK in isoform 2. 2 PublicationsAdd BLAST | 16 |
Sequence databases
| Select the link destinations: EMBLi GenBanki DDBJi Links Updated | U29171 mRNA. Translation: AAC50807.1. U31285 mRNA. Translation: AAC50808.1. AB091044 mRNA. Translation: BAC10903.1. AK291758 mRNA. Translation: BAF84447.1. EF015900 Genomic DNA. Translation: ABM64211.1. BC003558 mRNA. Translation: AAH03558.1. BC015775 mRNA. Translation: AAH15775.1. |
| CCDSi | CCDS11805.1. [P48730-1] CCDS11806.1. [P48730-2] |
| PIRi | G01876. |
| RefSeqi | NP_001884.2. NM_001893.4. [P48730-1] NP_620693.1. NM_139062.2. [P48730-2] |
| UniGenei | Hs.631725. |
Genome annotation databases
| Ensembli | ENST00000314028; ENSP00000324464; ENSG00000141551. [P48730-1] ENST00000392334; ENSP00000376146; ENSG00000141551. [P48730-2] |
| GeneIDi | 1453. |
| KEGGi | hsa:1453. |
| UCSCi | uc002kei.4. human. [P48730-1] |
Keywords - Coding sequence diversityi
Alternative splicing, PolymorphismSimilar proteinsi
Links to similar proteins from the UniProt Reference Clusters (UniRef) at 100%, 90% and 50% sequence identity:| 100% | UniRef100 combines identical sequences and sub-fragments with 11 or more residues from any organism into one UniRef entry. |
| 90% | UniRef90 is built by clustering UniRef100 sequences that have at least 90% sequence identity to, and 80% overlap with, the longest sequence (a.k.a seed sequence). |
| 50% | UniRef50 is built by clustering UniRef90 seed sequences that have at least 50% sequence identity to, and 80% overlap with, the longest sequence in the cluster. |
Entry informationi
| Entry namei | KC1D_HUMAN | |
| Accessioni | P48730Primary (citable) accession number: P48730 Secondary accession number(s): A2I2P2, Q96KZ6, Q9BTN5 | |
| Entry historyi | Integrated into UniProtKB/Swiss-Prot: | February 1, 1996 |
| Last sequence update: | January 27, 2003 | |
| Last modified: | July 5, 2017 | |
| This is version 181 of the entry and version 2 of the sequence. See complete history. | ||
| Entry statusi | Reviewed (UniProtKB/Swiss-Prot) | |
| Annotation program | Chordata Protein Annotation Program | |
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | |
Miscellaneousi
Caution
Was shown to phosphorylate and activate DCK in vitro but probably not in vivo.1 Publication
Keywords - Technical termi
3D-structure, Complete proteome, Reference proteomeDocuments
- Human chromosome 17
Human chromosome 17: entries, gene names and cross-references to MIM - Human entries with polymorphisms or disease mutations
List of human entries with polymorphisms or disease mutations - Human polymorphisms and disease mutations
Index of human polymorphisms and disease mutations - MIM cross-references
Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot - PDB cross-references
Index of Protein Data Bank (PDB) cross-references - Human and mouse protein kinases
Human and mouse protein kinases: classification and index - SIMILARITY comments
Index of protein domains and families
